CD44 and cancer: In our study, we aimed to determine whether OLE would directly target resistant cancer stem cells rather than healthy surrounding cells in the 3D breast model we have created of ER + MCF-7 CD44+/CD24- (CSC) cells and how OLE would affect their stemness, proliferative and metastatic properties of this population [27].